Polyclonal stimulation of CD8 § cytotoxic T lymphocytes (CTL) occurs during infection with many viruses including those not known to transform CTL or encode superantigens. This polyclonal CTL response includes the generation of high levels of allospecific CTL directed against many class I haplotypes. In this report we investigated whether the allospecific CTL generated during an acute lymphocytic choriomeningitis virus (LCMV) infection of C57BL/6 mice were stimulated specifically by antigen recognition or nonspecifically by polyclonal mechanisms possibly involving lymphokines or superantigens. An examination of the ability of different strains of mice to induce high levels of CTL specific for a given aUoantigen showed that most, but not all, strains generated high levels of allospecific CTL, and that their abilities to generate them mapped genetically to the major histocompatibility complex locus, exclusive of the class II region. This indicated that the virus-induced allospecific CTL generation was independent of the class II aUotype, and mice depleted of CD4 + cells generated allospecific CTL, indicating independence of class II-CD4 + cell interactions and resulting CD4 + cell-secreted lymphokines. FACS | staining with a variety of V:/-binding antibodies did not show a superantigen-like depletion or enrichment of any tested V/~ + subset during infection. Several experiments provided evidence in support of direct stimulation of CD8 + cells via the T cell receptor: (a) both virus-and allo-specific killing were enriched within a given V3 subpopulation; (b) relative CTL precursor frequencies against different class I alloantigens changed during the course of virus infection; (c) the relative levels of virusinduced, allospecific CTL-mediated lysis at day 8 after infection did not parallel the CTL precursor frequencies before infection; and (d) limiting dilution analyses of day 8 LCMV-infected spleen cells stimulated by virus-infected syngeneic peritoneal exudate cells (PEC) revealed not only the expected virus-specific CTL clones, but also a high frequency of clones that were cross-reactive with allogeneic and virus-infected syngeneic targets. In addition to the virus cross-reactive allospecific CTL clones, virus-infected PEC also stimulated the generation of some allospecific clones that did not lyse virus-infected fibroblasts. Surprisingly, LCMV-infected PEC were much more efficient at stimulating allospecific CTL clones from day 8 LCMV-infected splenocytes than were allogeneic stimulators. These results indicate that at least part of the polyclonal allospecific CTL response elicited by acute virus infection is a consequence of the selective expansion of many clones of allospecific CTL which cross-react with virus-infected cells. These CTL may contribute to the early control of virus infection, when the viral burden is great, and before significant numbers of high affinity virus-specific CTL are generated.
megalovirus (MCMV) in the mouse (4) , and with EBV in humans (5, 6) , Acute virus infections such as mouse hepatitis virus (strain JHM) (7) and Coxsackie B3 virus (CVB3) (8, 9) in the mouse and Kilham rat virus in the rat (10) have been reported to stimulate autoimmune T cells. The allospecitic CTL induced in mice by LCMV or in humans by EBV infection have been shown to recognize the class I antigens on a broad range of allogeneic targets, indicating that a large spectrum of TCR specificities are elicited (6) . This would suggest that virus infection causes many of the CD8 + T cells to proliferate and differentiate, and indeed, during the first 8 d of an acute LCMV infection, the number of CD8 + cells in the spleen increases 15-20-fold, whereas the total number of spleen cells increases two-four-fold over that of the uninfected spleen. Many of these virus-induced CD8 § T cells express activation markers. Approximately 75% express CD44, "~50% express CD11b (11) , and "~25% express the large granular lymphocyte phenotype of cytotoxic cells (12) .
The consequences of this polyclonal T cell response are as yet undetermined, but these CTL have the potential to contribute to autoimmunity and graft rejection. In addition, if the allospecific CTL represent selective expansions of virusspedfic CTL which are cross-reactive with alloantigens, they may provide an early, important, and rapidly mobilized immune response to control virus infection and spread in the host.
The question we address in this report is whether the profound levels of CD8 + cell proliferation and the induction of allospecific CTL are stimulated by an antigen-driven mechanism involving occupation of the TCK by viral or virusinduced antigens, or whether they are a consequence of a TCR-independent mechanism induced by the complex array of lymphokines produced during an acute virus infection. We have previously reported that the killing of allogeneic targets was not impaired by coincubation with unlabeled virusinfected syngeneic targets (4) . This argued that the allospedfic CTL response was not cross-reactive with the virus-specific response, and this result, along with the observation that targets expressing all tested allogeneic class I aUotypes (H2d'f'k'P 'r's) were lysed by CTL from C57BL/6 mice (H-2b), led us to speculate that this may be a cytokine-driven polyclonal response independent of TCR stimulation. However, we also discussed that affinity differences of the CTL for the targets in cold target competition assays could account for lack of competition for T cells that recognize both targets (4) .
The approach we have taken here to address these issues is to look for preferential selection of particular allospecifidties over others during virus infection, and to determine if the virus-induced allospecific CTL are cross-reactive with viral antigen at the clonal level. In addition, we map genetically the generation of virus-induced allospecific CTL to MHC regions external to the class II genes and demonstrate that CD4 + cells do not play a prominent role in this induction process. We report that there is an active selection of aUospecific CTL subsets during acute virus infection and that this can be attributed, at least in part, to cross-reactivity of virus-specific CTL clones for alloantigen.
Materials and Methods
Mice. Most strains of mice were purchased from The Jackson Laboratory (Bar Harbor, ME). These included the H-2 b strains C57BL/6J, C57BL/10J, and C3H.SW/SnJ; H-2 a strains BALB/cbyJ, DBA/2J and B10.D2/nSnJ; H-2 k strains C3H/HeSnJ and B10.BR/SgSnJ; and strains of other haplotypes such as B10.M/Sn (H-2f), C3H.NB/Sn (H-2P), SWR/J (H-2q), B10.RJII-(71NS)/SnJ (H-2r), and A.SW/SnJ (H-2'). The H-2' strain B10.S was purchased from Harlan Sprague Dawley, Inc. (Indianapolis, IN). The recombinant strains A.TBR1 (H-2 'tl) and A.TBR2 (H-2 '~2) (13) were kindly provided by Dr. Howard Pessmore (ILutgers University, New Brunswick, NJ). Mice were used at 1-6 mo of age.
Viruses. The Armstrong strain of LCMV was used in all experiments. The virus was propagated on baby hamster kidney calls as reported dsewhere (14) . Mice were injected intraperitoneally with 4 x 104 PFU of LCMV for 7 or 8 d unless otherwise indicated. LCMV-immune mice were given secondary LCMV infection by injection with 4 x 104 PFU of LCMV at least 4 wk after the primary LCMV infection. Target Cells, L929 (H-2k), a continuous liver cell line derived from C3H mice, and MC57G (H-2S), a methylcholanthreneinduced flbroblast cell line from C57BL/6 mice were propagated in MEM (Gibco Laboratories, Grand Island, NY) supplemented with 100 U/ml penicillin G, 100/,g/ml streptomycin sulfate, 2 mM t-glutamine, and 10% heat inactivated (56~ 30 rain) fetal bovine serum (FBS) (Sigma Chemical Co., St. Louis, MO). P815 (H-2a), a methylcholanthrene-induced mastocytoma from DBA/2 mice, was maintained in 1LPMI media (Sigma Chemical Co.) supplemented as described for complete MEM (c-RPMI). KO cells (H-2b), a SV40-transformed cell line derived from a C57BL/6 mouse (15) and provided to us by Dr, Satvir Tevethia (Pennsylvania State Medical Center, Hershey, PA) were propagated in DMEM (Gibco Laboratories) supplemented as described for MEM, but with the addition of 5 x 10 -s M 2qvt~ and 10 mM Hepes. MC57G, KO, and L929 cells were infected with LCMV at a multiplicity of infection (MOI) of 0.1-0.2 PFU/cell and incubated for 2 d at 37~
Depletion of NK Cells In Viw Mice were injected intraperitoneally with 5/,1 of antiserum to asialo GM1 (Wako Chemical, Dallas, TX) in a volume of 0.1 ml on days 0 and 4 after infection. This greatly reduced NK cell activity for at least an 8-d time period.
Effector (Respander) Cell Preparation. Spleens were isolated and ground between the frosted ends of two glass microscope slides. The cell suspension was then passed through a fine nylon mesh to obtain a single cell suspension. Erythrocytes were lysed by briefly resuspending the spleen cell pellet in 0.84% NH4C1 solution before rinsing. For CD8 + effector cells, 10 s spleen cells were stained with 50/,1 of directly FITC-conjugated, purified anti-CD8 antibody (Becton Dickinson & Co., Mountain View, CA) for 45 rain on ice and rinsed three times before sorting, The stained cells were compared with unstained cells for background fluorescence and separated into CD8-and CD8 + subpopulations at a flow rate of 2,000-2,500 cellsA using a cell sorter (FACS | 440; Becton Dickinson & Co. Ed Palmer (National Jewish Center for Immunology and Respiratory Medicine, Denver, CO) were used. The cells were incubated for 45 min on ice, rinsed three times, and treated with a mouse FITC-conjugated F(ab')z anti-rat IgG F(ab')z (Jackson Immunore-search Laboratories, West Grove, PA) or a biotin-conjugated rat anti-mouse Ig (Zymed, San Francisco, CA) for 30 rain on ice and rinsed three times. Streptavidin (Becton Dickinson & Co., San Jose, CA) was added to the biotin-treated samples for 30 rain on ice and washed three times. The stained cells were sorted as described above.
Cytotoxicity Assay. Cell-mediated cytotoxicity was determined using a standard microcytotoxicity (CTL) assay (16) . MC57G, KO, L929, or P815 target cells (1-5 x 106) were pelleted, resuspended in 0.1 ml of Na-SlCr (Amersham Corp., Arlington Heights, IL), and incubated for 45 min at 37~ in a humidified 5% COs incubator. The targets were rinsed three times in RPMI, resuspended to 10Vml in c-RPMI, and 0.05 or 0.1 ml was added to flatbottomed microtiter wells in quadruplicate (Costar Corp., Cambridge, MA). For the CD8 inhibition studies, 0.05 ml of anti-Lyt 2 antibody (dilution of M12:17.2 ascites, kindly provided by Dr. Eric Martz (University of Massachusetts, MA) (17) was added to the plates for the duration of the SlCr-release assay. Varying numbers of effector leukocytes were added in 0.1 ml of medium to achieve the desired E/T ratios. For a spontaneous SlCr-release control, 0.1 ml of c-RPMI was added to the labeled target cells in place of effector cells. For the maximum S~Cr-release control, 0.1 ml of 1% NP-40 was added to target cells. After 6-8 h at 37~ the microtiter plates were centrifuged at 200g for 5 min. Supernarant was removed (0.1 ml) from each well and counted on a gamma counter (model 5000; Beckman Instruments, Inc., Palo Alto, CA). Data were expressed as percent specific SlCr-release = 100 x [(experimental cpm -spontaneous release cpm)/maximum release cpm -spontaneous release cpm)]. Lyric units were calculated using the exponential fit and yon Kroegh methods (18) provided by software (Proteins International, Rochester Hills, MI). One lytic unit was defined as the number of effector cells required to lyse a given percentage of a population of 104 targets in an 8-h CTL assay.
In Vivo Depletion of eD4 § Cells. CD4 + cells were depleted following the procedure of Bullet et al. (19) . Briefly, 0.1 ml of GK 1.5 hybridoma ascites propagated in BALB/c mice in our facility, control ascites from BALB/c, or PBS was injected intraperitoneally on -4, -2, and +3 d after infection to deplete CD4 + cells. On the day of the assay, the mice were bled to determine IgG levels in the serum. The spleens were removed and used in cell-mediated cytotoxicity assays and FACS | analyses to determine the presence or absence of CD4 + cells using a mouse FITC-conjugated F(ab')2 anti-rat IgG F(ab')2 second antibody (Jackson Immunoresearch Laboratories). IgG levels were determined by cytoplasmic staining of fixed LCMV-infected MC57G cells using serial dilutions of control and CD4 + cell-depleted sera. The second antibody was a FITC-labeled goat anti-mouse IgG (Zymed).
Limiting Dilution Assay (LDA) for Virus-Specific CTL Precursors.
The assays used the procedure of Moskophides et al. (20) with the following modifications. Stimulators were prepared from peritoneal exudate cells (PEC), isolated from C57BL/6 mice having received 1 ml of thioglycollate broth (Difco Laboratories Inc., Detroit, MI) intraperitoneally before plating. The PEC were infected with an MOI of 0.1 PFU of LCMV and plated in 96-well, U-bottomed microtiter dishes (Costar Corp.) at 5 x 104 per/well in 0.1 ml culture media. After 2 d in culture, the 96-well plates received 2,000 rad of 137Cesium gamma irradiation from an irradiator (Gammacell 40; Atomic Energy of Canada, Ltd., Ottawa, Canada). Culture medium was removed (50 #1) from each well and replaced with 50 #1 of media containing 10 S irradiated (2,000 rad), syngeneic spleen cells. Varying numbers of responder cells from C57BL/6 spleens were added in 0.1 ml of media to 16-32 well replicates, and the plates were cultured at 37~ in a humidified COs (5%) incubator. After 4 d, the cultures were fed by removing 0.1 ml of media from each well and adding 5 x 104 irradiated, virusinfected PEC in 0.1 ml of media. The culture medium throughout the assay was either c-RPMI (Sigma Chemical Co.) supplemented with 0.1 mM nonessential amino acids (Gibco Laboratories), 0.1 #M sodium pyruvate (Gibco Laboratories), 1% 1 M Hepes, and 5 x 10-s M 2-ME (MLC-RPMI) or complete AIM V medium (Gibco Laboratories) supplemented with 10% heat-inactivated FCS. Growth factors were provided by the addition of 25% culture supematant from the IL-2-secreting, gibbon lymphoma tumor cell line MLA.144 (American Type Culture Collection, Rockville, MD) (21). On days 5-8 of culture, individual wells were split three-or fourfold and assayed for cytolytic function on infected or uninfected syngeneic target cells (MC57G or KO) and on allogeneic target cells (L929 and P815) using a modified SlCr-release assay. 51Cr-labeled targets (5 x 103) were added to all wells to allow a final volume of 200/zl/well. The plates were incubated 8 h at 37~ centrifuged for 5 min at 130 g (IEC CRU-5000 centrifuge), and 0.1 ml of supernatant was harvested. Radioactivity released into the supernatant was counted on a gamma counter (Beckman Instruments, Inc.). Positive wells were defined as those wells whose SlCr-release exceeded the mean spontaneous release by >3 SD. All wells that lysed uninfected syngeneic targets or lysed all targets tested were eliminated from the analysis. Frequencies were calculated using X 2 analysis according to Taswell (22) 
LDA to Determine Precursor Frequencies of Allospecific CTL. A1-
logeneic stimulator cells were prepared from the spleens of allogeneic mice irradiated (2,000 rad) 1 h before killing. Varying numbers of responder spleen cells (from infected or control mice) were cultivated in 96-well flat-bottomed microtiter plates (Costar Corp.) in the presence of 106 irradiated allogeneic spleen cells in 0.2 ml supernatant-supplemented MLC-RPMI (as described above). The cultures were incubated at 37~ in a humidified 5% COs atmosphere for 4 d, at which time they were fed by replacing 0.1 ml of the culture medium in each well with fresh supplemented MLC-RPMI. After 4 d more of culture, a modified SlCr-release assay and precursor analyses were performed as described above.
MLC. For micro MLC, 2 x 10 s irradiated, allogeneic stimulator cells were plated into flat-bottomed microtiter wells (Costar Corp.) Doses ranging from 25 to 200 x 104 responder cells in 0.1 ml volume of MLC-RPMI were added to the stimulators in replicas of four wells. The cultures were incubated in a 37~ humidified, 5% CO2 incubator for 4 d. SlCr-labeled target cells (10 4, P815, L929, and MC57G) in 50 #1 of c-RPMI were added to each culture well. For spontaneous release of SlCr, targets were added to wells containing only medium. For maximum release of S:Cr, targets were added to wells that contained 0.1 ml of 1% NP-40 in PBS. The plates were incubated for 6 h at 37~ in a humidified incubator, centrifuged at 130g, and 0.1 ml of supernatant was removed from each well and counted in a gamma counter (Beckman Instruments, Inc.). The percent specific 51Cr-release was calculated as described above. Standard MLC were prepared by incubating 2 x 107 effectors in the presence of 8 x 107 irradiated, allogeneic stimulator cells in 25 ml of MLC-RPMI in a 25 cm 2 flask (Costar Corp.). These were incubated in the upright position, 37~ in a humidified 5% CO2 incubator for 4 d. The viable cells were collected and used as effectors in the standard cytotoxicity assay described above.
Results

Induction of Allospecific CTL and Their Sensitivity to Treatment
with Anti-CD8 mAb. Table 1 (Expts. 1, 2, and 3) shows that at 8 d after primary infection, high levels of cytotoxicity develop against LCMV-infected syngeneic targets, and moderate levels of cytotoxidty develop against the uninfected allogeneic H-2 k and H-2 a targets. Virtually no cytotoxicity was observed against uninfected syngeneic targets in these mice, which had been depleted of NK cells. We have previously shown that this cytotoxic activity is mediated by CD8 § CTL (3). The CD8 molecule on the surface of CTL is responsible for strengthening low affinity interactions between the CTL and the target cell by binding to the o~3 domain of the class I MHC molecule (23) . Antibodies directed against CD8 are thought to inhibit the interactions of low affinity CTL more than those of high affinity (24) . We questioned whether there were differences in the CD8 requirements between the virusand allospecific CTL-mediated lysis. Table 1 shows the effects of anti-CD8 antibody on the lysis of LCMV-infected syngeneic targets (H-2 b + LCMV) and allogeneic targets (H-2 k and H-2 d) by day 8 LCMV-infected spleen cells in a SlCrrelease assay. With excess anti-CD8 antibody, there was significant inhibition in the lysis of both allogeneic and virusinfected syngeneic targets, though a small component of the virus-specific killing was not inhibited. This contrasts with the high affinity, uninhibitable interactions seen with alloor virus-specific CTL, respectively, from secondary MLC (Expts. 2 and 3) or from secondary in vivo virus infection (Expt. 4).
The Induction of Virus-Induced Allospecific CTL in Congenic
and Recombinant Strains of Mice. The levels of LCMV-induced allospecific CTL generation varied with the strain of mice (Fig. 1 ). H-2 k ~ar strains generated relatively low levels of lysis against the targets L929 (H-2 k) and P815 (H-2a); H-2 b, f, p, ,~d s strains generated high levels. We questioned what genetic factors contributed to this strain variation and tested the ability of various congenic mouse strains to generate anti-H-2 d CTL after LCMV infection. The allospecific CTL induction against H-2 a targets mapped within the MHC. Congenic strains that presented the H-2 b (C57BL/6, C57BL/ . Levels ofLCMV-induced allospecific CTL in different strains of mice. 100:1 E/T ratio. Data represent average lysis from six experiments using C57BL/6; four experiments using A.SW; three experiments using C3H.NB and C3H; two experiments using B10.RIII; and one experiment using B10.M and B10.S.
10, C3H.SW) haplotype generated higher levels of virusinduced H-2d-specific CTL than those that presented the H-2 k haplotype (B10.BR, C3H) (Fig. 2) . The C3H strain contains high NK cell activity, and it is sometimes difficult to completely eliminate its NK cell activity by anti-asialo GM, injections, as higher concentrations of anti-asialo GM1 inhibit CTL generation. To facilitate the distinction between nonspecific NK-like vs. allospecific cytotoxicity, the killing against syngeneic targets, presumably mostly NK cell mediated, is also presented in this figure. To more precisely map within the MHC locus the gene region which was associated with virus-induced alloreactivity, recombinant mice that ex- (Fig. 4) . Cytoplasmic staining of LCMV-infected MC57G cells with sera collected from the antibody-or sham-treated mice showed that the production of antiviral IgG, a CD4 § T cell-dependent event, was reduced by '~ 1,000-fold in the anti-CD4 antibodytreated mice, and FACS | showed that the lymphocyte population was largely depleted of CD4 § cells (data not shown).
These results indicate that the polyclonal stimulation of allospecific CTL during virus infection does not require high levels of the lymphokines secreted by the CD4 + T cell population.
Lack of Evidence for a CD8 + T Celt Superantigen Response.
"Superantigen"-encoding pathogens such as MMTV and Staphylococcus preferentially stimulate the expansion of peripheral CD4 § T cells expressing particular V3 in their TCR (2, 26) . To determine whether LCMV-induced allospecific CTL were the result of the expansion of CD8 + T cells activated by an LCMV-induced or -encoded superantigen, spleen cells from LCMV-infected and control C57BL/6 mice were stained with a panel of TCR V3 antibodies (V3 5, 6, 8, 9, 11, and 17). In confirmation of work reported previously for some of the V3 genes (27) , no skewing of the VB usage was apparent in the CTL population after 7 d of LCMV infection, arguing against the possibility that the allospecific CTL are responding to superantigen (data not shown).
Selective Expansion of 1-t-2 k vs. 1-1-2 d Allospecificity in the LCMV-infected C57BL/6 Mouse.
A possible mechanism for the induction of allospecific CTL during acute virus infection is that they are cross-reactive CTL selected to proliferate via TCR occupancy by a viral or endogenous antigen presented in the context of self MHC class I antigen. If so, the response should not be absolutely "polyclonal" but more oligoclonal, and the relative numbers of allospecific CTL (H-2 a vs. H-2 k) and their precursors before and after infection should change depending upon which alloantigen more closely resembles the conformation of self MHC and antigen that is driving Table 2 ). More often than not, the direct virus-induced allospecific CTL-mediated lysis was greater against the H-2 k (L929) cell target than the H-2 d (P815) cell target, even though these mice had twice as many H-2a-specific precursors before infection. These results demonstrate a greater selection of H-2 k-than H-2d-specific CTL and suggest that the virus-induced alloreactivity may be due to the selective expansion of discrete clones of allospecific CTL.
Representation of Both Virus-and H-2~-specific CTL in the Vff8 + Population of Virus-infected Spleen Cells. To determine
the relationship between the virus-and allospecific CTL, we questioned whether a population of T cells bearing a given VB and enriched for virus-specific CTL activity would also be enriched for allospecific CTL activity. The V3 8 TCR was selected because it is expressed on a greater number of T cells in the C57BL/6 mouse (27) than other V3 TCR for which there are antibodies. When LCMV-infected spleen cells were sorted using flow cytometry for expression of V3 8 + TCR, virus-and allospecific lysis were both highly represented in the V3 8 + population ( Table 3 ), suggesting that phenotypically similar cells are mediating both functions. This experiment also formerly proves that at least some of the allospecific CTL response is mediated by conventional CTL expressing TCR-3. Substantial virus-and allospecific CTL activity was also found in the V3 8-populations.
Cross-reactivity of Short-Term LCMVspecific CTL Clones Generated in LDA.
An explanation for the preferential selection of certain allospecific CTL specificities could be that the abundance of viral antigen present during acute virus infection stimulates the proliferation of any CTL with the capacity to bind or cross-react with the viral peptide-self-MHC class I complex. Some of these CTL might be cross-reactive with alloantigen. To determine if the selection of allospecific CTL was due to cross-reactivity with virus-infected cells, shortterm (4-8 d in culture) virus-specific CTL clones were generated in LDA and tested in split-well analyses for cross-reactivity against LCMV-infected and uninfected syngeneic (H-2 b) and uninfected H-2 k or H-2 d aUogeneic targets. Fig. 5 shows the LDA of CD8 + splenic T cells taken from mice at days 5, 7, 8, and 9 after infection. The precursor frequency of virusspecific CD8 § T cells derived from C57BL/6 mice peaked at 7 d of LCMV infection, but was estimated to be only 1 in 61 CD8 + spleen cells (Fig. 5) , despite the fact that most of the CD8 § cells at that time point have an activated
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Nahill and Welsh phenotype (11). This demonstrates how only a very small subpopulation of this activated CD8 + T cell population grows out in these LDA. The precursor frequency was determined for each experiment, and all the culture wells estimated to contain ~<0.5 virus-specific CTL/well were exposed to 5tCr-labeled allogeneic targets to determine if any of the virus-specific clones also lysed allogeneic targets. As can be seen in Table 4 , experiments 1-5 generated high levels of virusspecific CTL cross-reactive with H-2 k or H-2 d (27/78 or 35%) and used a commercially available, supplemented RPMI medium. Experiments 6-11 used an alternative medium, AIM V, which generated similar virus-specific CTL precursor frequencies but with greater rates of cell proliferation in the 8-d culture period. Lower, but still significant levels of CTL cross-reactive with H-2 k were stimulated with this proprietary medium (11/114 or 10%) ( Table 4 ). This lower level of cross-reactivity in the AIM V media suggests that the crossreactive allospecific CTL may have different growth requirements than some of the virus-specific CTL. The generation of the high levels of allospecific CTL clones required virus-infected PEC for their stimulation, suggesting that the clones must cross-react with virus-infected PEC. It could be argued, however, that a strong virus-specific T cell reaction might provide factors for a bystander stimulation of allospecific CTL without recognition of the virus-infected PEC by the allospecific CTL. Analyses indicated that the crossreactive CTL were, indeed, clones and not mixtures of two CTL clones, each with a different specificity. There was a linear single-hit distribution of aUospecific killing at limiting concentrations, indicating that the allospecific CTL were not dependent on a second (i.e., virus specific) T cell type for their generation. The precursor frequencies for the virusspecific CTL were not of a sufficient magnitude to contaminate all the wells of allospecific CTL precursors and to allow for linear allospecific kinetics in an environment of excess virusspecific "helper cells." Statistical analysis (X 2, goodness of fit) of the distribution of clones at <0.5 spleen cells/well showed that the cross-reactive clones were not merely due to the chance appearance of an alloreactive clone in the same well as a virus- specific clone, because many more wells showed lysis of both allogeneic and virus-infected targets than would have if the cross-reactivity were attributable to a random association of two dones (two-tail X 2 p value <0.001; Fisher value <0.001%). In summary, these analyses of short-term, virusspecific CTL clones show that a significant amount of the alloreactivity seen during LCMV infection can be attributed to virus-specific CTL that cross-react with allogeneic H-2 k or d MHC antigens (38/192 or 20%) (Table 4) and that the outgrowth of these CTL is sensitive to indeterminate factors present in media.
The Generation of Allospecific CTL Clones not Lrtic for Virusinfected Syngeneic Fibroblasts. The virus-specific, allo-crossreactive CTL clones generated in LDA did not account for all of the allospecific CTL clones. Split-well analyses also revealed allospecific dones that were stimulated to proliferate in vitro with virus-infected, syngeneic PECs, but were unable to lyse the infected, syngeneic fibroblast cell line, MC57G. Under the limiting conditions that generated 192 H-2 b plus virus-specific CTL clones (where the effector cell density was <0.5 virus-specific CTL/well), 35 clones were found to lyse only the allogeneic target, L929 (H-2 k) or P815 (H-2 d) or both, but not the virus-infected or uninfected syngeneic targets, MC57G or KO cells (Table 3 ). The generation of allospecific CTL occurred in the LDA cultures stimulated with virusinfected PEC but not with uninfected PEC (data not shown). The allospecific clones appeared in wells seeded with fewer than 250 spleen cells, which was a remarkably high frequency approaching that of virus-specific CTL. These results suggest that these allospecific CTL recognized (a) a viral antigen presented by LCMV-infected PEC, but not by virus-infected MC57G or KO cells; (b) virus-induced cellular antigens presented on the PEC; or (c) presented viral antigens with affinities sufficient for stimulation of proliferation and differentiation, but not sufficient for cytotoxicity against virus-infected targets.
Allospecific CTL Precursors Generated in Response to Alloeeneic Stimulators vs. Virus-infected Syngeneic Stimulators. When day
8 LCMV-infected spleen cells were stimulated with virusinfected PEC, the detected precursors for H-2 a-and H-2 kspecific CTL were much more frequent than when PEC expressing the respective alloantigen were used to stimulate the spleen cell population. The frequency of H-2k-specific precursors was 1 in 213 (p, 0.24; intercept, 1.01) in day 8 spleen cells using virus-infected PEC to stimulate, whereas H-2k-presenting stimulators (irradiated spleen cells from B10.BR or C3H mice) yielded an average precursor frequency of 1 in 3,407 from day 8 spleen cells (Table 2) . Similarly, the precursor frequencies for H-2a-specific CTL in acutely infected spleens was 1 in 346 (p, 0.31; intercept, 1.07) using virus antigen to stimulate vs. 1 in 3,739 using alloantigen to stimulate (Table 2 ). These surprising results in LDA indicate that in a virus-induced T cell population, viral antigen is better than alloantigen at inducing allospecific CTL precursors.
Stability of Cwss-reactive Clones. If more than one CTL clone was responding in the cross-reactive wells, one might expect that over time the specificity would drift toward one reactivity or be lost. This did not occur in six clones that were maintained for 4 wk in culture. The first clone maintained specificity for L929 (H-2k), the second was crossreactive for L929 (H-2 k) and virus antigen, the third was specific for P815 (H-2 d) and L929 (H-2k), and the remaining three were specific for virus-modified self (i.e., H-2 b + LCMV) but not H-2 a or H-2 k (Fig. 6 ).
Discussion
These results show that infection with a nontransforming virus elicits a profound polyclonal CTL response in the absence of any detectable V~-binding superantigens, as significant alterations in the numbers of cells expressing TCR V~ genes are not observed during infection. Although not all VB gene products were examined, the expansion of an untested V~ subset should still lead to a reduction in other subsets, which did not occur. A corollary of this polyclonal CTL response was the generation of low affnity, allospecific CTL, independent of CD4 + T cells or the allotype of the class II antigens. The target of the allospecific CTL was shown previously to be class I MHC antigens (4) , and the ability of various strains of mice to generate high levels of CTL to a given allotype mapped to the MHC locus outside of the class II region, and may in fact be a product of the T cell repertoire educated by host class I antigens. At least a portion of the allospecific CTL response generated during acute virus infection is due to a selective stimulation of many, though discrete, clones bearing cross-reactivity with syngeneic cells expressing viral antigen. Many of the allospecific CTL generated in vivo and detected directly in cytotoxicity assays probably have a low affnity for virus-modified self because unlabeled virus-infected targets did not interfere with the lysis of radiolabeled allogeneic targets in bulk cytotoxicity assays (3). Additionally, however, the allospecific CTL are themselves probably of low affinity, as their ability to lyse allogeneic targets is highly inhibitable by anti-CD8 antibody ( Table 1) . The large range of allogeneic haplotypes recognized (4) implies that the numbers of these allospecific CTL must be great. This may provide an explanation for why virus-specific precursor frequencies are only 1 in 61 CD8 + cells in the spleen (Fig. 5 ), yet 1 in 4 of the CD8 + ceUs in the day 7 LCMV-infected spleen have the large granular lymphocyte morphology characteristic of activated cytotoxic cells (12) . The majority of the CTL present in the acutely infected spleen may not proliferate in our LDA because their affnity for virus is too low, yet the allospecific CTL probably proliferate in vivo, as we have shown previously that both the allospecific and virus-specific cells are found in the blast-sized cell fractions (4).
"Affnity" as it is used here, is a loosely defined term which in the case of the CTL probably includes not only the physical affnity of the TCR for MHC plus peptide (which has been shown to be a very weak interaction) (28) , but also the interactions of accessory molecules and their receptors (CD2-LFA 3; CD8-MHC; CDllb-intercellular adhesion molecule (ICAM)-I or C3bi; and LFA-I-ICAM-1 or 2), as has been suggested by Williams et al. (29) . In contrast with the acute infection, the precursor frequencies of virus-specific CTL in the peritoneal cavity of mice 2 mo after infection correlate closely with the numbers of CD8 + CTL expressing the memory CDllb + phenotype in vivo (data not shown) and are quite high (>1 in 10), indicating that there is no inherent poor efficiency in generating precursors in the LDA and suggest that the LDA culture conditions may be favoring the proliferation of memory cells. The high frequency of crossreactive clones generated in short-term LDA from acutely infected splenocytes contrasts with reports on the specificities of a number of LCMV-specific clones generated in long-term, bulk cultures. These highly selected clones show no crossreactivity with H-2 a or k alloantigens (30) .
It is surprising that we found many CTL clones whose proliferation depended upon virus-infected PEC, but which were able to lyse only allogeneic cells but not virus-infected fibroblast targets. These CTL may have been cross-reactive for self PEC antigens induced by virus infection or for viral antigens presented by the virus-infected PEC used to stimulate their growth, but not presented on the virus-infected fibroblasts used for assaying their cytotoxicity. This distinction will be addressed in future experiments. Recently there have been reports of virus infections inducing autoimmune T cells in the mouse (7) (8) (9) and the rat (10) . Some of the allospecific CTL observed in our studies may be stimulated by a virus-induced, tissue-specific neo-antigen to which the host is not tolerized.
PV, MCMV, W, and LCMV induce allospecific CTL, suggesting that the aUospecific CTL induction is a normal part of the immune response to virus infection (4) . We propose that these cross-reactive CTL may play an important role in viral clearance at early times after infection when the viral burden is great, before high affinity CTL appear in large numbers. These cells may be directly cytotoxic to virus-infected targets in vivo or secrete cytokines amplifying other clearance mechanisms and possibly the proliferation of CD8 + cells. The fact that so many CD8 + cells respond to infection may provide an explanation as to why many virus-specific CTL responses do not require help from CD4 + T cells (25) . It has been suggested (Hagerty, D. T., and E M. Allen, manuscript submitted for publication) that high concentrations of antigen select a broad range of TCR affinities whereas low concentrations of antigen select high affinity T cells. LCMV grows to very high titers in the spleens of the mouse during the first few days of infection, and this would allow efficient antigen presentation to CTL with a broad range of affinities for virus plus MHC class I. Presumably, high affinity CTL would be selected as the virus is cleared, and antigen becomes rare.
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